Eva Hellqvist

1.3k total citations · 1 hit paper
14 papers, 964 citations indexed

About

Eva Hellqvist is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Eva Hellqvist has authored 14 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Eva Hellqvist's work include Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Lanthanide and Transition Metal Complexes (2 papers). Eva Hellqvist is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Lanthanide and Transition Metal Complexes (2 papers). Eva Hellqvist collaborates with scholars based in Sweden, United States and Germany. Eva Hellqvist's co-authors include Anders Rosén, Silke Sohn, Jonas Fuxe, Jeffrey V. Ravetch, Charlotte Rolny, Malin Sund, Robert A. Harris, Jeanette Östling, Fubin Li and Anna‐Maria Georgoudaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Eva Hellqvist

14 papers receiving 953 citations

Hit Papers

Reprogramming Tumor-Associated Macrophages by Antibody Ta... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
    2016 441 citations Anna‐Maria Georgoudaki, Vanessa F. Boura et al. Cell Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hellqvist Sweden 9 497 313 249 243 157 14 964
Nadja Zaborsky Austria 18 386 0.8× 283 0.9× 336 1.3× 256 1.1× 138 0.9× 49 945
Shahrzad Jalali United States 17 383 0.8× 199 0.6× 406 1.6× 196 0.8× 213 1.4× 39 952
Thomas Hawthorne United States 20 421 0.8× 274 0.9× 660 2.7× 145 0.6× 85 0.5× 40 1.2k
Antonella Vallario Italy 12 389 0.8× 369 1.2× 290 1.2× 295 1.2× 157 1.0× 17 857
Julie A. McEarchern United States 13 384 0.8× 387 1.2× 537 2.2× 132 0.5× 189 1.2× 25 1.0k
Javier Redondo-Muñóz Spain 16 225 0.5× 576 1.8× 251 1.0× 234 1.0× 76 0.5× 27 990
Alexander W. Macfarlane United States 15 534 1.1× 219 0.7× 432 1.7× 70 0.3× 117 0.7× 30 940
Paul R. Gielen Netherlands 9 741 1.5× 455 1.5× 501 2.0× 143 0.6× 31 0.2× 11 1.2k
Patricia Amé-Thomas France 17 774 1.6× 189 0.6× 562 2.3× 279 1.1× 467 3.0× 29 1.2k
Vinay Sagar United States 19 142 0.3× 712 2.3× 361 1.4× 190 0.8× 65 0.4× 46 1.3k

Countries citing papers authored by Eva Hellqvist

Since Specialization
Citations

This map shows the geographic impact of Eva Hellqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellqvist more than expected).

Fields of papers citing papers by Eva Hellqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hellqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellqvist. The network helps show where Eva Hellqvist may publish in the future.

Co-authorship network of co-authors of Eva Hellqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hellqvist. A scholar is included among the top collaborators of Eva Hellqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hellqvist. Eva Hellqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jin, Yi, Kenian Chen, Eva Hellqvist, et al.. (2018). Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma. Blood. 131(19). 2138–2150. 58 indexed citations
2.
Georgoudaki, Anna‐Maria, Vanessa F. Boura, Eva Hellqvist, et al.. (2016). Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis. Cell Reports. 15(9). 2000–2011. 441 indexed citations breakdown →
3.
Holm, Frida, Eva Hellqvist, Cayla Mason, et al.. (2015). Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal. Proceedings of the National Academy of Sciences. 112(50). 15444–15449. 37 indexed citations
4.
Holm, Frida, Eva Hellqvist, Cayla Mason, et al.. (2014). Malignant Reprogramming of Progenitors into Leukemia Stem Cells Is Enhanced By Upregulation of CD44 Transcript Variant 3 in Malignant Microenvironments. Blood. 124(21). 511–511. 1 indexed citations
5.
Holm, Frida, Eva Hellqvist, Christian Barrett, et al.. (2014). Abstract 4798: The niche specific role of CD44 splice isoform expression in blast crisis leukemia stem cell generation. Cancer Research. 74(19_Supplement). 4798–4798. 1 indexed citations
6.
Hellqvist, Eva, Mattias Jansson, Kenneth Nilsson, et al.. (2013). Molecular characterization of neoplastic and normal “sister” lymphoblastoid B-cell lines from chronic lymphocytic leukemia. Leukemia & lymphoma. 54(8). 1769–1779. 14 indexed citations
7.
Hellqvist, Eva, Frida Holm, Valeria Runza, et al.. (2013). CD44 Monoclonal Antibody-Enhanced Clearance Of Chronic Myeloid Leukemia Stem Cells From The Malignant Niche. Blood. 122(21). 858–858. 4 indexed citations
8.
Rosén, Anders, Eva Hellqvist, Magnus Björkholm, et al.. (2012). Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. OncoImmunology. 1(1). 18–27. 48 indexed citations
9.
Hellqvist, Eva, Christina Wu, George F. Widhopf, et al.. (2012). Selective Clearance of Chronic Lymphocytic Leukemia Cells in Vivo Following Treatment with UC99961, an Anti-ROR1 Monoclonal Antibody. Blood. 120(21). 3886–3886. 1 indexed citations
10.
Hellqvist, Eva, Marika Kvarnström, Anita Söderberg, et al.. (2009). Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells. Haematologica. 95(4). 627–636. 5 indexed citations
11.
Klasson, Anna, Maria Ahrén, Eva Hellqvist, et al.. (2008). Positive MRI contrast enhancement in THP‐1 cells with Gd2O3 nanoparticles. Contrast Media & Molecular Imaging. 3(3). 106–111. 55 indexed citations
12.
Klasson, Anna, Maria Ahrén, Eva Hellqvist, et al.. (2008). Positive MRI contrast enhancement in THP-1 cells with Gd2O3 nanoparticles.. PubMed. 3(3). 106–11. 14 indexed citations
13.
Hellqvist, Eva, Anita Söderberg, Helen Baxendale, et al.. (2008). A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. Blood. 111(7). 3838–3848. 199 indexed citations
14.
Gunnarsson, Cecilia, et al.. (2005). 17β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer. British Journal of Cancer. 92(3). 547–552. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nadja Zaborsky Breakdown of academic impact, for papers by Shahrzad Jalali Breakdown of academic impact, for papers by Thomas Hawthorne Breakdown of academic impact, for papers by Antonella Vallario Breakdown of academic impact, for papers by Julie A. McEarchern Breakdown of academic impact, for papers by Javier Redondo-Muñóz Breakdown of academic impact, for papers by Alexander W. Macfarlane Breakdown of academic impact, for papers by Paul R. Gielen Breakdown of academic impact, for papers by Patricia Amé-Thomas Breakdown of academic impact, for papers by Vinay Sagar
Rankless by CCL
2026